Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healthcare Biotechnology
Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Healios KK Ord Shs > order status
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by ama21968on Dec 03, 2010 6:36pm
205 Views
Post# 17799066

RE: order status

RE: order status

That is nothing and fake !!!  relax kid! it is not a issue at all,

-- "Trading is Tech, Manipulation is ART ".

1. Look at BMK today for example, all large sell orders are FAKE.
2. Halo is trading at as cheap as 9 Million MC when Friday close which is still 0.02 $ /lb zinc with anything else copper gold zinc... for FREE! 
3. Should ask youself  WHY INSIDERS bought 250000 common shares at 0.51$ at open market on Dec 1st?
4. It has been said, "FISHY SMELL". --- FINANCING is coming soon anytime... maybe Monday.. you never know 
5. Someone wants to sell zinc at just 2 cents pre lb, so follow them if you want...
6. Cold and Lost JV contains :  ( They are OPEN PIT #s ONLY!!!!!)

0.28 Million ozs Gold;
0.61Million oze Silver,
33.4 Million lbs Copper,
87Million lbs Zinc

HBM pays everything till prodcution ... without any cost for Halo!!! plus Free cash flow start in 12 Months.

Mark my words here (But could be wrong ): HBM is coming to the table to finance Halo for entire Sherridon VMS. just dont know the "TERM" ...

Massage SP... GLTA

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities